发明名称 CEPHALOSPORINSALZE UND INJIZIERBARE MITTEL
摘要 Crystalline sulfuric, di-nitric, mono-hydrochloric, di-hydrochloric, and di- and sesqui-orthosphosphoric acid addition salts of 7-[ alpha -(2-aminothiazol-4-yl)- alpha -(Z)-methoxyimino-acetamido]-3-[(1-methyl-1-pyrrolidinio)methyl]-3-cep hem-4- carboxylate are stable even at elevated temperatures. The crystalline sulfuric acid addition salt is made by forming an admixture of (a) at least one molar equivalent of sulfuric acid with (b) zwitterion in an amount so as to be present in the admixture at a concentration of greater than 25 milligrams/ml, causing crystallization, separating the crystals, washing and drying. The crystalline monohydrochloride, dihydrochloride, and orthophosphate salts are prepared by dissolving the zwitterion in the appropriate amount of acid, causing crystallization by adding acetone and isolating the crystals. Physical admixtures of the salts with certain bases in proportions to give a pH ranging from about 3.5 to about 7 on dilution with water provide injectable compositions on dilution.
申请公布号 DE3901359(A1) 申请公布日期 1989.10.05
申请号 DE19893901359 申请日期 1989.01.18
申请人 BRISTOL-MYERS CO., NEW YORK, N.Y., US 发明人 KAPLAN, MURRAY ARTHUR, SYRACUSE, N.Y., US;HUDYMA, THOMAS W., DURHAM, CONN., US;LIPPER, ROBERT ALAN, MANLIUS, N.Y., US;SHIH, KUN MAO, EAST SYRACUSE, N.Y., US;BOETTGER, SUSAN D., SYRACUSE, N.Y., US
分类号 C07D501/00;A61K31/40;A61K31/425;A61K31/545;A61K31/546;A61K47/00;A61K47/18;C07D;C07D501/04;C07D501/38;C07D501/46;C07D501/56;C07D501/60 主分类号 C07D501/00
代理机构 代理人
主权项
地址